Latest Development Activity News

Athena Resources has kicked off a new drilling program at its Byro South Prospect and progressed metallurgical testing, alongside a successful $2.67 million capital raise and a key leadership appointment.

Enova Mining reports significant high-grade titanium discoveries at its CODA North and Central projects in Brazil, supported by a $1.5 million placement to accelerate exploration and development.

Corella Resources has successfully completed a fully underwritten rights issue raising $935,487, positioning the company to advance exploration at its Tampu Project and consider new opportunities.

Imagion Biosystems has progressed its MagSense HER2 breast cancer imaging agent towards a pivotal Investigational New Drug application with the FDA, backed by a solid funding runway exceeding 13 quarters.

EMU NL's latest quarterly report reveals promising copper exploration parallels with Canada’s Highland Valley mine and renewed gold project interest, alongside significant management changes and a pending shareholder showdown.

Moho Resources has finalized the sale of its Empress Springs Project with revised payment terms, while progressing a promising soil sampling program at its Silver Swan gold project. The company remains focused on portfolio optimization and shareholder value.

Moho Resources has amended the sale terms of its Empress Springs Project with Qld Aus Graphite, replacing a royalty agreement with upfront cash payments totaling $708,500. Completion is expected soon, pending final conditions.

Renascor Resources reports significant engineering advances that increase high-value graphite production by 60%, reduce operating costs, and confirm a safer, eco-friendly purification process.

Tungsten Mining NL has made significant strides in developing its Mt Mulgine and Hatches Creek projects, with a maiden Mineral Resource Estimate for Hatches Creek expected soon and key environmental approvals progressing.

Australian Rare Earths Limited (ASX: AR3) has secured a $5 million government grant to advance its Koppamurra Rare Earths Project, confirmed promising uranium mineralisation at its Overland Project, and raised $3.6 million through a rights issue to accelerate development.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

Piche Resources has reported significant advances in its March 2025 quarter, extending gold-silver mineralisation at Cerro Chacon and confirming upgraded high-grade uranium assays at Ashburton, while unveiling new uranium zones at Sierra Cuadrada.